- Home
- VTYX vs NIU Comparison
VTYX vs NIU Comparison
Compare VTYX & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- NIU
- Stock Information
- Founded
- VTYX 2018
- NIU 2014
- Country
- VTYX United States
- NIU China
- Employees
- VTYX N/A
- NIU N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- NIU Auto Manufacturing
- Sector
- VTYX Health Care
- NIU Consumer Discretionary
- Exchange
- VTYX Nasdaq
- NIU Nasdaq
- Market Cap
- VTYX 148.4M
- NIU 141.2M
- IPO Year
- VTYX 2021
- NIU 2018
- Fundamental
- Price
- VTYX $1.73
- NIU $1.80
- Analyst Decision
- VTYX Buy
- NIU
- Analyst Count
- VTYX 5
- NIU 0
- Target Price
- VTYX $8.40
- NIU N/A
- AVG Volume (30 Days)
- VTYX 1.1M
- NIU 548.2K
- Earning Date
- VTYX 11-07-2024
- NIU 11-18-2024
- Dividend Yield
- VTYX N/A
- NIU N/A
- EPS Growth
- VTYX N/A
- NIU N/A
- EPS
- VTYX N/A
- NIU N/A
- Revenue
- VTYX N/A
- NIU $420,244,416.00
- Revenue This Year
- VTYX N/A
- NIU $31.46
- Revenue Next Year
- VTYX N/A
- NIU $29.83
- P/E Ratio
- VTYX N/A
- NIU N/A
- Revenue Growth
- VTYX N/A
- NIU 5.83
- 52 Week Low
- VTYX $1.67
- NIU $1.57
- 52 Week High
- VTYX $11.48
- NIU $3.50
- Technical
- Relative Strength Index (RSI)
- VTYX 30.10
- NIU 34.56
- Support Level
- VTYX $2.10
- NIU $1.75
- Resistance Level
- VTYX $2.36
- NIU $2.03
- Average True Range (ATR)
- VTYX 0.12
- NIU 0.11
- MACD
- VTYX -0.05
- NIU -0.05
- Stochastic Oscillator
- VTYX 8.76
- NIU 8.47
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, moped and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.